Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioXcel Therapeutics (BTAI) Interest & Investment Income (2022 - 2025)

Historic Interest & Investment Income for BioXcel Therapeutics (BTAI) over the last 4 years, with Q3 2025 value amounting to $236000.0.

  • BioXcel Therapeutics' Interest & Investment Income fell 6168.83% to $236000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 6500.0%. This contributed to the annual value of $2.6 million for FY2024, which is 5393.88% down from last year.
  • According to the latest figures from Q3 2025, BioXcel Therapeutics' Interest & Investment Income is $236000.0, which was down 6168.83% from $230000.0 recorded in Q2 2025.
  • In the past 5 years, BioXcel Therapeutics' Interest & Investment Income registered a high of $2.0 million during Q1 2023, and its lowest value of $15000.0 during Q1 2022.
  • For the 4-year period, BioXcel Therapeutics' Interest & Investment Income averaged around $768333.3, with its median value being $671000.0 (2024).
  • Its Interest & Investment Income has fluctuated over the past 5 years, first surged by 1333333.33% in 2023, then plummeted by 7053.85% in 2025.
  • BioXcel Therapeutics' Interest & Investment Income (Quarter) stood at $1.5 million in 2022, then tumbled by 36.34% to $946000.0 in 2023, then tumbled by 61.1% to $368000.0 in 2024, then crashed by 35.87% to $236000.0 in 2025.
  • Its Interest & Investment Income was $236000.0 in Q3 2025, compared to $230000.0 in Q2 2025 and $279000.0 in Q1 2025.